Hitoshi Miyakoshi

Hitoshi Miyakoshi joined Taiho ventures in 2021. He worked at Taiho Pharmaceutical for 16 years as a medicinal chemist in drug discovery for anti-cancer agents. He led cancer metabolism and brain cancer projects as a chemistry leader, including dUTPase/DPD dual inhibitor (TAS-114) and brain-penetrable drug discovery projects. Besides that, he also engaged in open-innovation support in a wide range of drug discovery field at Taiho. He received his PhD in pharmaceutical and medicinal chemistry from Gifu Pharmaceutical University.